INCREASE IN PERIPHERAL NATURAL KILLER CELL ACTIVITY IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE

References

• Herberman R B, Nunn M E, Lavrin D H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J Cancer 1975; 16: 216–229
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Santoli D. Anti‐viral activity induced by culturing lymphocytes with tumor‐derived or virus‐transformed cells. J Exp Med 1978; 147: 1314–1333
   PubMed Web of Science ®Google Scholar
• Vyakarnam A, Brenner M K, Reittie J E, Houlker C H, Lach‐mann P J. Human clones with natural killer function can activate B cells and secrete B cell differentiation factors. Eur J Immunol 1985; 15: 606–610
   PubMed Web of Science ®Google Scholar
• Kimata H, Sherr E H, Saxon A. Human natural killer (NK) cells produce a late‐acting B‐cell differentiation activity. J Clin Immunol 1988; 8: 381–389
   PubMed Web of Science ®Google Scholar
• Arai S, Yamamoto H, Itoh K, Kumagai K. Suppressive effect of human natural killer cells on pokeweed mitogen induced B cell differentiation. J Immunol 1983; 131: 651–657
   PubMed Web of Science ®Google Scholar
• Morio T, Nonoyama S, Yata J. Suppression of in vitro immunoglobulin synthesis by CD 16 (Leulla)+ CD56 (NKH1, Leul9)+ non‐T lineage NK cells; lack of suppression of cells from immunodeficient patients. Clin Exp Immunol 1989; 78: 159–165
   PubMed Web of Science ®Google Scholar
• Katz P, Zaytoun A M, Lee J H, Jr, Panush R S, Longley S. Abnormal natural killer cell activity in systemic lupus erythematosus an intrinsic defect in the lytic event. J Immunol 1982; 129: 1966–1971
   PubMed Web of Science ®Google Scholar
• Pedersen B K, Oxholm P. Impaired release of natural killer cytotoxic factor in patients with primary Sjogren's syndrome. Clin Exp Immunol 1988; 72: 299–302
   PubMedGoogle Scholar
• Cifone M G, Giacomelli R, Famularo G, Paolini R, Danese C, Napolitano T, et al. Natural killer activity and antibody‐dependent cellular cytotoxicity in progressive systemic sclerosis. Clin Exp Immunol 1990; 80: 360–365
   Google Scholar
• Sack J, Baker J R, Jr, Weetman A P, Wartofsky L, Burman K D. Killer cell activity and antibody‐dependent cell‐mediated cytotoxicity are normal in Hashimoto's disease. J Clin Endocrinol Metab 1986; 62: 1059–1064
   Google Scholar
• Pedersen B K, Feldt‐Rasmussen U, Bech K, Perrild H, Klarlund K, Hoier‐Madsen M. Characterization of the natural killer cell activity in Hashimoto's and Graves' diseases. Allergy 1989; 44: 477–81
   Google Scholar
• Papic M, Stein‐Strcilein J, Zakarija J M, McKenzie M, Guffee J, Fletcher M A. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest 1987; 79: 404–408
   Google Scholar
• Wang P, Luo S, Huang B, Lin J, Huang M. Depressed natural killer activity in Graves' disease and during antithyroid medication. Clin Endocrinol 1988; 28: 205–214
   Google Scholar
• Pedersen B K, Perrild H, Feldt‐Rasmussen U, Christensen T, Klarlund K, Molholm H. Suppressed natural killer cell activity in patients with euthyroid Graves' ophthalmopathy. Autoimmunity 1989; 2: 291–298
   PubMed Web of Science ®Google Scholar
• Yang J, Zucker‐Franklin D. Modulation of natural killer (NK) cells by autologous neutrophils and monocytes. Cell Immunol 1984; 86: 171–186
   Google Scholar
• Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I, et al. High prevalence of transient post‐partum thyrotoxicosis and hypothyroidism. N Engl J Med 1982; 306: 849–852
   PubMed Web of Science ®Google Scholar
• Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, et al. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab 1982; 55: 108–112
   PubMed Web of Science ®Google Scholar
• Hidaka Y, Amino N, Iwatani Y, Kaneda T, Mitsuda N, Morimoto Y, et al. Changes of natural killer cell activity in normal pregnant and postpartum women: increases in the first trimester and postpartum period and decrease in late pregnancy. J Reprod Immunol 1991; 20: 73–83
   Google Scholar
• Amino N, Aozasa M, Tamaki H, Tachi J, Mori M, Iwatani Y, . Increase of peripheral natural killer (NK) cells at postpartum destructive thyrotoxicosis in autoimmune thyroid disease. Recent Progress in Thyroidology, Vichayanrat, et al. Crystal House, Bangkok 1987; 294–299
   Google Scholar
• Iwatani Y, Amino N, Tamaki H, Aozasa M, Kabutomori O, Mori M, et al. Increase in peripheral large granular lymphocytes in postpartum autoimmune thyroiditis. Endocrinol Japan 1988; 35: 447–453
   Google Scholar
• Hayslip C C, Baker J R, Jr, Wartofsky L, Klein T A, Opsahl M S, Burman K D. Natural killer cell activity and serum autoantibodies in women with postpartum thyroiditis. J Clin Endocrinol Metab 1988; 66: 1089–1093
   PubMedGoogle Scholar
• Amino N, Miyai K. Postpartum autoimmune endocrine syndromes. Autoimmune Endocrine Disease, T Davis. John Wiley & Sons, New York 1983; 247–272
   Google Scholar
• Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K. Serial changes in thyroid‐stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Clin Endocrinol Metab 1987; 65: 324–330
   Google Scholar
• Iwatani Y, Amino N, Tachi J, Kimura M, Ura I, Mori M, et al. Changes of lymphocyte subsets in normal pregnant and postpartum women: postpartum increase of NK/K (Leu7) cells. Am J Reprod Immunol 1988; 18: 52–55
   Google Scholar
• Mori M, Amino N, Iwatani Y, Kabutomori K, Asari S, Motoi S, et al. Increase of peripheral B lymphocytes in Graves' disease. Clin Exp Immunol 1980; 42: 33–40
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Amino N, Kaneda T, Ichihara K, Tamaki H, Tachi J, et al. Marked increase of CD5+ B cells in hyperthyroid Graves' disease. Clin Exp Immunol 1989; 78: 196–200
   PubMed Web of Science ®Google Scholar
• Aozasa M, Amino N, Iwatani Y, Tamaki H, Matsuzuka F, Kuma K, et al. Intrathyroidal HLA.‐DR‐positive lymphocytes in Hashimoto's disease: increases in CD8 and Leu7 cells. Clin Immunol Immunopathol 1989; 52: 516–522
   Google Scholar
• Aozasa M, Amino N, Iwatani Y, Tamaki H, Tachi J, Fujiyasu S, et al. Separation and analysis of mononuclear cells infiltrating the thyroid of patients with Graves' disease. Clin Immunol Immunopathol 1987; 43: 343–353
   Google Scholar
• Ueki Y, Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Tezuka H, et al. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease. J Clin Endocrinol Metab 1989; 69: 939–945
   PubMedGoogle Scholar
• Tezuka H, Eguchi K, Fukuda T, Otsubo T, Kawabe Y, Ueki Y, et al. Natural killer and natural killer‐like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease. J Clin Endocrinol Metab 1988; 66: 702–707
   PubMed Web of Science ®Google Scholar